NEW YORK STATE COMMON RETIREMENT FUND - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 168 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$2,493,000
+179.8%
33,136
-0.2%
0.00%
+200.0%
Q1 2022$891,000
-43.7%
33,190
+0.1%
0.00%
-50.0%
Q4 2021$1,582,000
-46.9%
33,168
-26.0%
0.00%
-33.3%
Q3 2021$2,979,000
-26.1%
44,838
-13.2%
0.00%
-25.0%
Q2 2021$4,032,000
-9.8%
51,684
+9.3%
0.00%
-20.0%
Q1 2021$4,472,000
-34.1%
47,276
-15.1%
0.01%
-37.5%
Q4 2020$6,788,000
+54.5%
55,706
+10.8%
0.01%
+60.0%
Q3 2020$4,393,000
+105.9%
50,281
+52.2%
0.01%
+66.7%
Q2 2020$2,134,000
+51.6%
33,036
+4.8%
0.00%
+50.0%
Q1 2020$1,408,000
-28.3%
31,5360.0%0.00%0.0%
Q4 2019$1,964,000
+325.1%
31,536
+156.9%
0.00%
+100.0%
Q3 2019$462,000
-7.6%
12,2760.0%0.00%0.0%
Q2 2019$500,00012,2760.00%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,392,297$291,501,0006.94%
Burrage Capital Management LLC 72,484$8,832,0006.73%
MPM BioImpact LLC 617,372$75,226,0006.50%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 113,541$13,816,0003.77%
Orbimed Advisors 2,745,327$334,518,0002.93%
SECTORAL ASSET MANAGEMENT INC 257,379$31,362,0002.21%
Parkman Healthcare Partners LLC 59,377$7,235,0001.85%
Nicholas Investment Partners, LP 183,676$22,381,0001.73%
EMERALD ADVISERS, LLC 357,038$43,505,0001.44%
EMERALD MUTUAL FUND ADVISERS TRUST 336,173$40,963,0001.42%
View complete list of TURNING POINT THERAPEUTICS I shareholders